Form 4 Tracker
Jamie L. Reynoso

CEO, Medicare Advantage · 13 filings · Latest: Jul 17, 2026

CLOVER HEALTH INVESTMENTS, CORP. /DE
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
CLOV
Jamie L. ReynosoCEO, Medicare AdvantageJul 17, 2026
Sale
$4.534,839$21.9K2,814,640
CLOV
JAMIE REYNOSOJul 17, 2026
Proposed Sale
$4.404,839$21.3K
CLOV
Jamie L. ReynosoCEO, Medicare AdvantageJul 15, 2026
Sale
$4.6713,119$61.3K2,819,479
CLOV
Jamie ReynosoJul 15, 2026
Proposed Sale
$4.6812,712$59.5K
CLOV
Jamie L. ReynosoCEO, Medicare AdvantageJul 8, 2026
Sale
$4.682,384$11.2K2,832,598
CLOV
JAMIE REYNOSOJul 8, 2026
Proposed Sale
$5.002,384$11.9K
CLOV
Jamie L. ReynosoCEO, Medicare AdvantageJul 6, 2026
Sale
$5.266,229$32.8K2,834,982
CLOV
Jamie ReynosoJul 6, 2026
Proposed Sale
$5.266,229$32.8K
CLOV
Jamie L. ReynosoCEO, Medicare AdvantageJun 17, 2026
Sale
$4.782,360$11.3K2,841,211
CLOV
JAMIE REYNOSOJun 17, 2026
Proposed Sale
$4.942,360$11.7K
CLOV
Jamie L. ReynosoCEO, Medicare AdvantageJun 15, 2026
Sale
$4.616,350$29.3K2,843,571
CLOV
Jamie ReynosoJun 15, 2026
Proposed Sale
$4.817,556$36.3K
CLOV
Jamie L. ReynosoCEO, Medicare AdvantageJun 11, 2026
Sale
$4.917,289$35.8K2,849,921
CLOV
JAMIE REYNOSOJun 11, 2026
Proposed Sale
$4.897,289$35.6K
CLOV
Jamie L. ReynosoCEO, Medicare AdvantageMar 18, 2026
Sale
$1.915,833$11.1K2,716,735
CLOV
JAMIE REYNOSOMar 18, 2026
Proposed Sale
$1.935,833$11.3K
CLOV
Jamie L. ReynosoCEO, Medicare AdvantageJan 20, 2026
Sale
$2.584,597$11.9K2,737,700
CLOV
JAMIE REYNOSOJan 20, 2026
Proposed Sale
$2.544,597$11.7K
CLOV
JAMIE REYNOSOJan 7, 2026
Proposed Sale
$2.592,102$5.4K
CLOV
JAMIE REYNOSODec 18, 2025
Proposed Sale
$2.604,913$12.8K

Page 1 of 2

Next →